Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Amphenol Corporation's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $201.6B | |
|---|---|---|
| Revenue (ttm) | 33B | |
| Net income (ttm) | 5.9B | |
| EPS (ttm) | $2.30 | |
| Shares out | 2.5B | |
| P/E (trailing) | 35.3x | |
| P/E (forward) | 24.8x | |
| Dividend | $0.50 (0.62%) | |
| Volume | 15,747,565 | |
| Beta | 1.24 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $10.88B | $12.62B | $12.55B | $15.22B | $23.09B | +20.7% |
| Gross profit | $3.40B | $4.03B | $4.08B | $5.14B | $8.52B | +25.8% |
| Operating income | $2.11B | $2.59B | $2.56B | $3.16B | $5.87B | +29.2% |
| Net income | $1.59B | $1.90B | $1.93B | $2.42B | $4.27B | +28.0% |
| EPS (diluted) | $1.27 | $1.53 | $1.55 | $1.92 | $3.34 | +27.3% |
| EBITDA | $2.50B | $2.99B | $2.56B | $3.80B | $6.89B | +28.8% |
| R&D | $317.7M | $323.6M | $342.2M | $453.0M | $647.0M | +19.5% |
| SG&A | $1.23B | $1.42B | $1.49B | $1.86B | $2.55B | +20.0% |
Recent company headlines from major financial publishers.
The base path assumes FY2027 revenue stays within the dated analyst range and operating cash remains above reported profit. Those are the observable confirmation tests.
The bull path assumes architecture discussions produce reported production positions. The cited remarks establish broad technology coverage and customer access, but not production wins.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.3% | $140 | $149 | $159 | $172 | $189 |
| 8.3% | $121 | $126 | $133 | $141 | $151 |
| 9.3% | $107 | $110 | $115 | $120 | $126 |
| 10.3% | $95.6 | $98.3 | $101 | $105 | $109 |
| 11.3% | $86.7 | $88.8 | $91.1 | $93.7 | $96.6 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
